Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Linde Bangladesh's Sloan Ratio for the quarter that ended in Jun. 2026 was -1.64%.
As of Jun. 2026, Linde Bangladesh has a Sloan Ratio of -1.64%, indicating the company is in the safe zone and there is no funny business with accruals.
Linde Bangladesh (DHA:LINDEBD) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Jun. 2026, Linde Bangladesh has a Sloan Ratio of -1.64%, indicating the company is in the safe zone and there is no funny business with accruals.
Linde Bangladesh Sloan Ratio % Related Terms
Linde Bangladesh Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Linde Bangladesh's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:LINDEBD vs LIN, SHW, ECL: Sloan Ratio % Comparison
For the Specialty Chemicals subindustry, Linde Bangladesh's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linde Bangladesh Sloan Ratio % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Linde Bangladesh's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Linde Bangladesh's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Linde Bangladesh's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
Linde Bangladesh's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was 98.599 (Sep. 2025 ) + 57.788 (Dec. 2025 ) + 109.932 (Mar. 2026 ) + 84.587 (Jun. 2026 ) = BDT351 Mil.
Linde Bangladesh's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was 63.507 (Sep. 2025 ) + 242.058 (Dec. 2025 ) + 31.931 (Mar. 2026 ) + 237.509 (Jun. 2026 ) = BDT575 Mil.
Linde Bangladesh's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 was 29.637 (Sep. 2025 ) + -111.467 (Dec. 2025 ) + -21.465 (Mar. 2026 ) + -36.411 (Jun. 2026 ) = BDT-140 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linde Bangladesh (DHA:LINDEBD) has a Sloan Ratio % of -1.64% as of Jun. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Linde Bangladesh and its competitors.
Is Linde Bangladesh's Sloan Ratio % too high?
Linde Bangladesh's current Sloan Ratio % is -1.64%. Overall, Linde Bangladesh has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Linde Bangladesh's Sloan Ratio % compare to LIN and SHW?
Linde Bangladesh's Sloan Ratio % of -1.64% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Chemicals company?
A good Sloan Ratio % depends on the Chemicals industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Linde Bangladesh and its competitors. Linde Bangladesh's current Sloan Ratio % is -1.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linde Bangladesh stock overvalued right now?
Based on GuruFocus' analysis, Linde Bangladesh (DHA:LINDEBD) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT902.30, compared to a current price of BDT696.40 — trading 22.8% below its estimated fair value. The current Sloan Ratio % is -1.64%. Linde Bangladesh's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Linde Bangladesh (DHA:LINDEBD), the current Sloan Ratio % is -1.64% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linde Bangladesh (DHA:LINDEBD) Overvalued in 2026?
Based on GuruFocus' analysis, Linde Bangladesh stock appears to be undervalued.
The current stock price of BDT696.40 is trading 22.8% below its estimated GF Value™ of BDT902.30.
GuruFocus considers Linde Bangladesh to be Modestly Undervalued.
Key valuation signals for DHA:LINDEBD:
Sloan Ratio %: -1.64%
GF Value™: BDT902.30 vs. price of BDT696.40 (22.8% below fair value)
No single metric tells the full story. See the DHA:LINDEBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Linde Bangladesh Ltd is a multinational industrial and medical gases company. The company provides products and services within a specific economic environment and supplies customers across a wide spectrum of industries ranging from chemicals and petrochemicals to steel. It operates 2 Air Separation Units (ASUs), 2 carbon dioxide manufacturing plants, and a DA manufacturing plant in the country. It serves various end markets such as chemicals and energy, food, beverage, electronics, healthcare, manufacturing, metals, defense, infrastructure, aerospace, and institutions. Its segments include Bulk Gases; Packaged Gas and Products; and the Healthcare business, which generates maximum revenue and comprises various medical gases, medical equipment, and medical pipelines.
73GF Score
Get the complete analysis for DHA:LINDEBD
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:LINDEBD has been successfully added to your 
